Professor Tufail is one of the leading ophthalmic surgeons in the UK. He is the clinical and research lead at Moorfields Eye Hospital in London for age-related macular degeneration. He has worked as a consultant here since 2002, and is an Honorary Senior Lecturer at University College London Institute of Ophthalmology.
Professor Tufail’s main subspecialty is medical retina disorders - with current areas of research including novel therapies for dry AMD, choroidal neovascularization, and diabetic retinopathy. Professor Tufail has published more than 80 peer-reviewed journal articles. But most notably, he was a co-principal investigator in the seminal ABC Trial examining bevacizumab for neovascular AMD. The ABC Trial became a cornerstone for anti-VEGF treatment protocols for wet-AMD therapy within the NHS.
Professional Qualifications
MBBS, MD, FRCOphth
Special Interest
Complicated cataract surgery
Professional body registration with number (eg. GMC/GDC)
Your appointment details have been forwarded to the doctor via email. You will receive a confirmation from them shortly. Thank you for choosing us for your healthcare needs.
We use cookies to give you the best possible experience on our website. By continuing to browse this site, you give consent for cookies to be used.
For more details please read our Cookie Policy
Manage Cookie Preferences
Strictly Necessary Cookies
These cookies are required for the website to work and cannot be switched off.
Analytical/ performance cookies
These cookies help us understand how visitors use our website by collecting anonymous information. They allow us to improve performance, identify issues, and enhance the overall user experience.
Functionality cookies
These cookies remember your preferences and settings, such as language or region, to provide a more personalised experience when you return to the website.
Targeting cookies
These cookies are used to deliver more relevant content and advertisements based on your browsing activity. They may also be used by trusted third-party partners to measure the effectiveness of advertising campaigns.
